212 related articles for article (PubMed ID: 31315995)
1. CD69 Targeting Enhances Anti-vaccinia Virus Immunity.
Notario L; Redondo-Antón J; Alari-Pahissa E; Albentosa A; Leiva M; Lopez D; Sabio G; Lauzurica P
J Virol; 2019 Oct; 93(19):. PubMed ID: 31315995
[TBL] [Abstract][Full Text] [Related]
2. CD69 Deficiency Enhances the Host Response to Vaccinia Virus Infection through Altered NK Cell Homeostasis.
Notario L; Alari-Pahissa E; de Molina A; Lauzurica P
J Virol; 2016 Jul; 90(14):6464-6474. PubMed ID: 27147744
[TBL] [Abstract][Full Text] [Related]
3. Weak vaccinia virus-induced NK cell regulation of CD4 T cells is associated with reduced NK cell differentiation and cytolytic activity.
Hatfield SD; Daniels KA; O'Donnell CL; Waggoner SN; Welsh RM
Virology; 2018 Jun; 519():131-144. PubMed ID: 29715623
[TBL] [Abstract][Full Text] [Related]
4. Selective reconstitution of IFN‑γ gene function in Ncr1+ NK cells is sufficient to control systemic vaccinia virus infection.
Borst K; Flindt S; Blank P; Larsen PK; Chhatbar C; Skerra J; Spanier J; Hirche C; König M; Alanentalo T; Hafner M; Waibler Z; Pfeffer K; Sexl V; Sutter G; Müller W; Graalmann T; Kalinke U
PLoS Pathog; 2020 Feb; 16(2):e1008279. PubMed ID: 32023327
[TBL] [Abstract][Full Text] [Related]
5. CD69 does not affect the extent of T cell priming.
Alari-Pahissa E; Notario L; Lorente E; Vega-Ramos J; Justel A; López D; Villadangos JA; Lauzurica P
PLoS One; 2012; 7(10):e48593. PubMed ID: 23119065
[TBL] [Abstract][Full Text] [Related]
6. Insufficient Innate Immunity Contributes to the Susceptibility of the Castaneous Mouse to Orthopoxvirus Infection.
Earl PL; Americo JL; Moss B
J Virol; 2017 Oct; 91(19):. PubMed ID: 28747505
[TBL] [Abstract][Full Text] [Related]
7. Natural Killer Cells and Innate Interferon Gamma Participate in the Host Defense against Respiratory Vaccinia Virus Infection.
Abboud G; Tahiliani V; Desai P; Varkoly K; Driver J; Hutchinson TE; Salek-Ardakani S
J Virol; 2016 Jan; 90(1):129-41. PubMed ID: 26468539
[TBL] [Abstract][Full Text] [Related]
8. Induction of tumor NK-cell immunity by anti-CD69 antibody therapy.
Esplugues E; Vega-Ramos J; Cartoixà D; Vazquez BN; Salaet I; Engel P; Lauzurica P
Blood; 2005 Jun; 105(11):4399-406. PubMed ID: 15692061
[TBL] [Abstract][Full Text] [Related]
9. Anti-CD69 therapy induces rapid mobilization and high proliferation of HSPCs through S1P and mTOR.
Notario L; Alari-Pahissa E; Albentosa A; Leiva M; Sabio G; Lauzurica P
Leukemia; 2018 Jun; 32(6):1445-1457. PubMed ID: 29483712
[TBL] [Abstract][Full Text] [Related]
10. CD69 targeting differentially affects the course of collagen-induced arthritis.
Sancho D; Gómez M; Martinez Del Hoyo G; Lamana A; Esplugues E; Lauzurica P; Martinez-A C; Sánchez-Madrid F
J Leukoc Biol; 2006 Dec; 80(6):1233-41. PubMed ID: 16921025
[TBL] [Abstract][Full Text] [Related]
11. Dengue Virus-Infected Dendritic Cells, but Not Monocytes, Activate Natural Killer Cells through a Contact-Dependent Mechanism Involving Adhesion Molecules.
Costa VV; Ye W; Chen Q; Teixeira MM; Preiser P; Ooi EE; Chen J
mBio; 2017 Aug; 8(4):. PubMed ID: 28765218
[TBL] [Abstract][Full Text] [Related]
12. Local antigen in nonlymphoid tissue promotes resident memory CD8+ T cell formation during viral infection.
Khan TN; Mooster JL; Kilgore AM; Osborn JF; Nolz JC
J Exp Med; 2016 May; 213(6):951-66. PubMed ID: 27217536
[TBL] [Abstract][Full Text] [Related]
13. In vivo antiviral effect of interleukin 18 in a mouse model of vaccinia virus infection.
Tanaka-Kataoka M; Kunikata T; Takayama S; Iwaki K; Ohashi K; Ikeda M; Kurimoto M
Cytokine; 1999 Aug; 11(8):593-9. PubMed ID: 10433806
[TBL] [Abstract][Full Text] [Related]
14. Enhanced antitumor immunity in mice deficient in CD69.
Esplugues E; Sancho D; Vega-Ramos J; Martínez C; Syrbe U; Hamann A; Engel P; Sánchez-Madrid F; Lauzurica P
J Exp Med; 2003 May; 197(9):1093-106. PubMed ID: 12732655
[TBL] [Abstract][Full Text] [Related]
15. Development of an animal model of progressive vaccinia in nu/nu mice and the use of bioluminescence imaging for assessment of the efficacy of monoclonal antibodies against vaccinial B5 and L1 proteins.
Zaitseva M; Thomas A; Meseda CA; Cheung CYK; Diaz CG; Xiang Y; Crotty S; Golding H
Antiviral Res; 2017 Aug; 144():8-20. PubMed ID: 28495463
[TBL] [Abstract][Full Text] [Related]
16. The DC receptor DNGR-1 mediates cross-priming of CTLs during vaccinia virus infection in mice.
Iborra S; Izquierdo HM; Martínez-López M; Blanco-Menéndez N; Reis e Sousa C; Sancho D
J Clin Invest; 2012 May; 122(5):1628-43. PubMed ID: 22505455
[TBL] [Abstract][Full Text] [Related]
17. CD69 is a stimulatory receptor for natural killer cell and its cytotoxic effect is blocked by CD94 inhibitory receptor.
Borrego F; Robertson MJ; Ritz J; Peña J; Solana R
Immunology; 1999 May; 97(1):159-65. PubMed ID: 10447727
[TBL] [Abstract][Full Text] [Related]
18. Profile of natural killer cells after a previous natural Vaccinia virus infection in an in vitro viral re-exposure.
Moreira-Silva EA; Medeiros-Silva DC; Gomes Jde A; da Fonseca FG; Correa-Oliveira R
Virus Res; 2014 May; 184():20-9. PubMed ID: 24530576
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic and functional characteristics of hematopoietic cell lineages in CD69-deficient mice.
Lauzurica P; Sancho D; Torres M; Albella B; Marazuela M; Merino T; Bueren JA; Martínez-A C; Sánchez-Madrid F
Blood; 2000 Apr; 95(7):2312-20. PubMed ID: 10733501
[TBL] [Abstract][Full Text] [Related]
20. IL-12 and IL-18 act in synergy to clear vaccinia virus infection: involvement of innate and adaptive components of the immune system.
Gherardi MM; Ramírez JC; Esteban M
J Gen Virol; 2003 Aug; 84(Pt 8):1961-1972. PubMed ID: 12867626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
